Skip to main content

Cyanotech Corp

CYAN
Exchange
OTC
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0000768408

No open-market purchases or sales by Cyanotech Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of CYAN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cyanotech Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Cyanotech Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

11 Schedule 13D and 13G filings on Cyanotech Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CYAN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 3, 2024Davis Michael A13D/AOld format–––SEC
Sep 12, 2024Davis Michael A13D/AOld format–––SEC
Sep 6, 2024Davis Michael A13D/AOld format–––SEC
Aug 15, 2024Davis Michael A13D/AOld format–––SEC
Jul 26, 2024Davis Michael A13D/AOld format–––SEC
Dec 20, 2023Davis Michael A13D/AOld format–––SEC
Aug 30, 2023Ginungagap Foundation13D/AOld format–––SEC
Aug 29, 2023Davis Michael A13D/AOld format–––SEC
Aug 29, 2023Ginungagap Foundation13DOld format–New–SEC
Apr 2, 2021Meridian OHC Partners, LP13D/AOld format–––SEC
Mar 10, 2021Wells Fargo & Company13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Cyanotech Corp shares.

No Form 144 notices for Cyanotech Corp are on file.